Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.37% |
| 2 | Healthcare | 7.45% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Industrials | 5.1% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
CALL
Equity Residential
EQR
$25.2B
| $5.44M | ﹤0.01% |
82,500
+15,500
| +23% | +$969K |
|
|
AFTR
2552
DELISTED
AfterNext HealthTech Acquisition Corp
AFTR
| $5.44M | ﹤0.01% |
525,000
-20,000
| -4% | -$206K |
|
2553
MacroGenics
MGNX
$240M
| $5.43M | ﹤0.01% |
1,014,549
-939,801
| -48% | -$5.8M |
|
2554
Floor & Decor
FND
$5.98B
| $5.42M | ﹤0.01% |
52,179
-1,240
| -2% | -$119K |
|
2555
Minerals Technologies
MTX
$2.25B
| $5.42M | ﹤0.01% |
94,024
+43,175
| +85% | +$2.51M |
|
2556
Ardmore Shipping
ASC
$703M
| $5.41M | ﹤0.01% |
438,460
-1,135,582
| -72% | -$15.2M |
|
|
PDS
2557
Precision Drilling
PDS
$979M
| $5.41M | ﹤0.01% |
110,934
-169,705
| -60% | -$8.1M |
|
2558
Prestige Consumer Healthcare
PBH
$2.37B
| $5.41M | ﹤0.01% |
91,094
+67,017
| +278% | +$4.01M |
|
2559
Benchmark Electronics
BHE
$2.85B
| $5.41M | ﹤0.01% |
209,441
-342,563
| -62% | -$7.92M |
|
|
ALLK
2560
DELISTED
Allakos
ALLK
| $5.4M | ﹤0.01% |
1,238,703
+343,338
| +38% | +$1.54M |
|
2561
CRA International
CRAI
$1.19B
| $5.39M | ﹤0.01% |
52,890
-28,774
| -35% | -$2.9M |
|
2562
Enterprise Financial Services Corp
EFSC
$2.39B
| $5.38M | ﹤0.01% |
137,715
+121,556
| +752% | +$5.03M |
|
2563
CALL
Welltower
WELL
$170B
| $5.38M | ﹤0.01% |
66,500
+16,100
| +32% | +$1.24M |
|
2564
Vipshop
VIPS
$7.3B
| $5.37M | ﹤0.01% |
325,414
+116,398
| +56% | +$1.82M |
|
2565
Credit Acceptance
CACC
$5.81B
| $5.37M | ﹤0.01% |
10,564
+3,528
| +50% | +$1.65M |
|
2566
Willis Towers Watson
WTW
$31.7B
| $5.36M | ﹤0.01% |
22,761
-310,415
| -93% | -$71.5M |
|
2567
Vera Therapeutics
VERA
$2.37B
| $5.36M | ﹤0.01% |
333,689
-1,553,662
| -82% | -$14M |
|
|
RPC
2568
Ridgepost Capital
RPC
$941M
| $5.35M | ﹤0.01% |
473,603
+155,880
| +49% | +$1.65M |
|
2569
Independent Bank
INDB
$4.02B
| $5.35M | ﹤0.01% |
120,192
-3,835
| -3% | -$199K |
|
2570
iShares Russell 1000 Growth ETF
IWF
$120B
| $5.35M | ﹤0.01% |
77,752
-66,960
| -46% | -$4.26M |
|
2571
Silgan Holdings
SLGN
$4.34B
| $5.34M | ﹤0.01% |
113,923
-351,360
| -76% | -$17.1M |
|
2572
Selective Insurance
SIGI
$5.64B
| $5.34M | ﹤0.01% |
55,615
-134,395
| -71% | -$13.2M |
|
2573
GXO Logistics
GXO
$5.8B
| $5.34M | ﹤0.01% |
84,927
+76,337
| +889% | +$4.28M |
|
2574
PUT
Cintas
CTAS
$82.7B
| $5.32M | ﹤0.01% |
42,800
+36,800
| +613% | +$4.32M |
|
2575
Zentalis Pharmaceuticals
ZNTL
$350M
| $5.31M | ﹤0.01% |
188,320
+158,926
| +541% | +$3.81M |
|
Similar funds
Millennium Management's Q2 2023 Portfolio in Review
As of Q2 2023, Millennium Management held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Millennium Management deployed $14B of net new capital in Q2 2023, opening 869 new positions and adding to 2,214 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, up from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.
- Millennium Management's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Millennium Management added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Millennium Management's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Millennium Management fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Millennium Management's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Millennium Management opened 869 new positions and closed 1,192 in Q2 2023.
- Millennium Management's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.